A comparative pharmacokinetic and pharmacodynamic study of two novel Cuban PEGylated rHuEPO versus MIRCERA® and ior®EPOCIM [0.03%]
两种古巴产PEG重组人促红细胞生成素与MIRCERA和ior®EPOCIM的比较药代动力学及药效学研究
Gledys Reynaldo,Leyanis Rodríguez,Roberto Menéndez et al.
Gledys Reynaldo et al.
Context: The recombinant human erythropoietin (rHuEPO) stimulates the erythropoiesis process. Because this glycoprotein has a short half-life, it needs to be administrated two to three times a week. One of the technics to...